Research and Markets: Gemzar (Ovarian Cancer) - Analysis and Forecasts to 2020 - Arlington Heights Daily Herald

Dublin - Research and Markets (http://www.researchandmarkets.com/research/t7z4ws/gemzar_ovarian_ca) has announced the addition of GlobalData 's new report "Gemzar (Ovarian Cancer) - Analysis and Forecasts to 2020" to their offering. GlobalData's ...

Abdominal fluid build up, now on Gemzar - American Cancer Society

I just joined this network and am wondering if anyone has any insight or experience with Gemzar chemotherapy and whether it works on abdominal fluid build up. My mom was diagnosed with advanced primary peritoneal/ovarian cancer 10/08. She initially had ...

Doxil and/or Gemzar and Radiation - American Cancer Society

Hola from the ovarian board. I know that many of you receive chemo and radiation for uterine cancer. Ovarian cancer patients don't generally receive radiation, but I know a woman with Clear Cell, who has read research saying her chances are improved with ...

Incyte rides wave after Pfizer's FDA panel nod - FierceBiotech

Lilly, which has lost major products such as the cancer drug Gemzar to generic competition, could benefit from buying partner Incyte, Jason Chew, a biotech analyst and co-founder of Chimera Research, told FierceBiotech. "A deal for Incyte would ...

Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical Sales and Marketing - Yahoo Finance

His major product launch successes include Prozac®, Ceclor®, Gemzar®, Humulin®, Enbrel® and Effexor XR®. Mr. Jooste received his diploma in Pharmacy from Pretoria Technikon in South Africa, and a Bachelor of Commerce, Economics and ...

"Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020" Published - SBWire

Analysis and Forecasts to 2020 - Gemzar (Pancreatic Cancer) - Analysis and Forecasts to 2020 - GV1001 (Pancreatic Cancer) - Analysis and Forecasts to 2020

Cancer specialists look to combination drug treatments, supporting the cytotoxic market - Transworld News

This is predicted to lead to a decrease in overall market value. Major cytotoxic brands such as Taxotere (docetaxel) by Sanofi and Gemzar (gemcitabine) by Eli Lilly are currently the most commercially successful brands, with Taxotere achieving sales of $1 ...

Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - msnbc.com

Gemcitabine (Gemzar), Goserelin (Zoladex), Herceptin SC, Icrucumab, IMP 321, Indibulin, Iniparib, Irinotecan (Campotsar), Ixabepilone (Ixempra), KW 2450, Lapatinib (Tykerb), Letrozole (Femara), Leuprorelin depot (Carcinil), Litronesib ...

Syracuse Basketball Icon Jim Boeheim Joins Cellceutix to Fight Cancer - Yahoo Finance

where he played a key role in lead selection and pre-clinical development of blockbuster cancer drugs Gemzar and Alimta which earned him a President's Recognition Award from Eli Lilly. Headquartered in Beverly, Massachusetts, Cellceutix is a ...

Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020 - new market research report - Transworld News

The patent expiries of major branded products, such as Taxol (paclitaxel), Paraplatin (carboplatin), Gemzar (gemcitabine), Hycamtin (topotecan hydrochloride) and the subsequent launch of generics, have acted as restraining factors to the market.